Simply Wall St.3d agobullish
Did Earnings Beat Just Shift Gilead Sciences' (GILD) Investment Narrative?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
108last 24h
3128last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires9d agobullish
UBS Adjusts Gilead Sciences Price Target to $195 From $175, Maintains Buy RatingStocktwits170d agobullish
GILD Stock Jumps After Winning Accelerated FDA Approval For HDV TreatmentSimply Wall St.176d agobullish
Evaluating Gilead Sciences (GILD) Valuation After Q1 Beat Guidance Shift And New HIV Priority ReviewBarrons.com178d agobullish
Tomato Prices Aren’t the Only Problem. How Retirees Can Beat Inflation.